1-T cell targeting chimeric antigen receptor (CAR) regulatory T cells (Tregs) for graft-versus-host-disease (GvHD) prevention Dre Chiara Bernardi, Departement d’Oncologie HUG 2-153sm-fapi-46 radioligand therapy with high-molar activity 153s Dr Thierry Sora, CERN 3-Counteracting Progression Mechanisms to Overcome Immune Checkpoint Inhibitor
